Akkın, S.; Varan, G.; Işık, A.; Gökşen, S.; Karakoç, E.; Malanga, M.; Esendağlı, G.; Korkusuz, P.; Bilensoy, E.
Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal Cancer. Pharmaceutics 2023, 15, 314.
https://doi.org/10.3390/pharmaceutics15020314
AMA Style
Akkın S, Varan G, Işık A, Gökşen S, Karakoç E, Malanga M, Esendağlı G, Korkusuz P, Bilensoy E.
Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal Cancer. Pharmaceutics. 2023; 15(2):314.
https://doi.org/10.3390/pharmaceutics15020314
Chicago/Turabian Style
Akkın, Safiye, Gamze Varan, Anıl Işık, Sibel Gökşen, Elif Karakoç, Milo Malanga, Güneş Esendağlı, Petek Korkusuz, and Erem Bilensoy.
2023. "Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal Cancer" Pharmaceutics 15, no. 2: 314.
https://doi.org/10.3390/pharmaceutics15020314
APA Style
Akkın, S., Varan, G., Işık, A., Gökşen, S., Karakoç, E., Malanga, M., Esendağlı, G., Korkusuz, P., & Bilensoy, E.
(2023). Synergistic Antitumor Potency of a Self-Assembling Cyclodextrin Nanoplex for the Co-Delivery of 5-Fluorouracil and Interleukin-2 in the Treatment of Colorectal Cancer. Pharmaceutics, 15(2), 314.
https://doi.org/10.3390/pharmaceutics15020314
